Niagen Bioscience Inc. files Form 4 with SEC

au.investing.com

Niagen Bioscience Inc. filed a Form 4 with the SEC on July 8, 2026. The filing likely details changes in beneficial ownership of securities by company insiders. This is a standard regulatory requirement for public companies. Form 4 filings are publicly accessible and provide transparency into insider trading activities.


With a significance score of 1, this news ranks in the top 65% of today's 33157 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Niagen Bioscience Inc. files Form 4 with SEC | News Minimalist